Factors related to psychotic symptoms in patients with Parkinson’s disease
Objective: The aim of this study was to compare clinical characteristics in Parkinson's disease (PD) with psychosis (PDP) versus PD without psychosis (PDnP) and evaluate…Blinded video assessment of subtle Parkinsonian signs in PREDICT-PD participants
Objective: To determine whether risk estimates calculated in PREDICT-PD are associated with objective motor features on clinical examination. Background: PREDICT-PD aims to identify a group…The International Parkinson and Movement Disorder Society – non-motor rating scale (MDS-NMS): Results from the cognitive pre-testing and phases 1 and 2 of an international validation
Objective: To revise the Non-Motor Sumptom Scale (NMSS) and develop a new up to date version, the MDS-NMS, a project commissioned by the International Parkinson…Self-perception of vocal handicap in Parkinson’s disease
Objective: The objective of this study was to evaluate self-perception of vocal handicap in individuals with Parkinson's disease at various stages of diagnosis. Background: The…Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease
Objective: To study characteristic of lipid levels in patients with PD. Background: Currently, there is no clear data about the features of lipid metabolism in…Dynamic prediction for multiple repeated measures and event time data: An application to Parkinson’s disease
Objective: To develop methods for model-based personalized dynamic prediction of future outcome measure trajectories and risks of target events for the Parkinson's disease patients. Background:…Effects of safinamide in patients with Parkinson’s disease measured by Parkinson’s KinetiGraphTM
Objective: To objectively evaluate the effects of Safinamide in patients with Parkinson's (PD) by using the Parkinson's KinetiGraphTM (PKG), a newly developed tool for graphically…Day case initiation of subcutaneous apomorphine in people with Parkinson’s disease: A retrospective analysis from a UK teaching hospital
Objective: To evaluate a cohort of people with Parkinson's disease (PD) who were initiated on subcutaneous apomorphine injections or continuous subcutaneous apomorphine infusions (CSAI) on…Histology of subcutaneous nodules in PD patients treated with continuous apomorphine infusion: Case series and review of the literature
Objective: To examine the histology of subcutaneous nodules after continuous subcutaneous apomorphine infusion (CSAI). Background: CSAI has been used successfully in advanced Parkinson's disease (PD).…Exercise-induced adaptive neuroplasticity in the MPTP mouse model of Parkinson’s disease
Objective: To increase our understanding of how physical exercise may drive adaptive neuroplasticity in a mouse model of Parkinson's disease (PD). Background: PD is a…
- « Previous Page
- 1
- …
- 371
- 372
- 373
- 374
- 375
- …
- 388
- Next Page »